---
schema_version: "secwatch.filing_event.v1"
accession: "0000897101-22-000946"
form_type: "8-K"
ticker: "ELMD"
cik: "0001488917"
company_name: "Electromed, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:23:19.074892+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Electromed Q1 FY2023 revenue up 7% to $10.7M; net income drops to $0.01 EPS

## Summary
- Net revenue $10.7M, +7% YoY; net income $81K ($0.01 diluted EPS) vs $439K ($0.05) last year.
- Operating income $44K vs $538K a year ago; SG&A up 17.7% due to legal fees and annual sales meeting.
- Cash $6.0M, down $2.2M from June 30; repurchased $145K of stock in quarter.
- Next-generation 510(k) submitted to FDA; limited market release expected in fiscal Q2 if clearance by mid-Dec.

## SEC filing metadata
- accession: 0000897101-22-000946
- form_type: 8-K
- ticker: ELMD
- cik: 0001488917
- company_name: Electromed, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/0000897101-22-000946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/elmd221300_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000897101-22-000946
- JSON: https://secwatch.observer/filing/0000897101-22-000946.json
- Plain text: https://secwatch.observer/filing/0000897101-22-000946.txt

## Key facts
- Earnings Releases
  Electromed, Inc. reported the three months ended September 30, 2022 results: revenue $10.7 million, net income $81,000, EPS $0.01 per diluted share.
  - Period: the three months ended September 30, 2022
  - Revenue: $10.7 million
  - Net income: $81,000
  - EPS: $0.01 per diluted share
  - Result: reported results
  source text: Net revenue was $10.7 million for the three months ended September 30, 2022, a 7% increase from $10.0 million for the three months ended September 30, 2021 ("Q1 FY 2022")
  evidence_url: https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/0000897101-22-000946-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.